READETT; David Robert John
Patent Applications and Registrations
Patent applications and USPTO patent grants for READETT; David Robert John.The latest application filed is for "anti-ctla-4 and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment".
- READETT; David Robert John - Mystic CT
| Patent | Date |
|---|---|
| Anti-ctla-4 And Cpg-motif-containing Synthetic Oligodeoxynucleotide Combination Therapy For Cancer Treatment App 20120003179 - READETT; David Robert John ; et al. | 2012-01-05 |
| Anti-Ctla-4 Antibody and Cpg-Motif-Containing Synthetic Oligodeoxynucleotide Combination Therapy for Cancer Treatment App 20090117132 - Readett; David Robert John ; et al. | 2009-05-07 |
| Combinations And Methods Of Using An Immunomodulatory Oligodeoxynucleotide App 20090082295 - Jungnelius; Jarl Ulf Birger ; et al. | 2009-03-26 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 